Sahid, Samina .
HRN: 25-23-97 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/02/2024
CEFTRIAXONE 1G (VIAL)
06/02/2024
06/09/2024
IV
1.5g
Q12 Hours
T/c Leptospirosis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes